Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 3 Nov 22 4 OmniAb Operations / KURT A GUSTAFSON ownership change
- 3 Nov 22 4 Change in insider ownership
- 3 Nov 22 4 OmniAb Operations / MATTHEW W FOEHR ownership change
- 3 Nov 22 4 OmniAb Operations / Charles S Berkman ownership change
- 2 Nov 22 15-12G Securities registration termination
- 30 Sep 22 3 OmniAb / MATTHEW W FOEHR ownership change
- 30 Sep 22 3 OmniAb / Charles S Berkman ownership change
- 30 Sep 22 3 OmniAb / KURT A GUSTAFSON ownership change
- 30 Sep 22 3 Initial statement of insider ownership
- 28 Sep 22 10-12G/A Registration of securities (amended)
- 24 Aug 22 10-12G Registration of securities
- 10 Jun 22 RW Registration withdrawal request
-
27 Apr 22 10-12G Registration of securities
OABIV similar filings
Filing view
External links
Exhibit 21.1
List of Principal Subsidiaries of the Registrant
In connection with the separation of the Registrant from Ligand Pharmaceuticals Incorporated, the following entities will become wholly owned subsidiaries of the Registrant.
Wholly Owned Subsidiary | Place of Incorporation | |
Ab Initio Biotherapeutics, Inc. | Delaware | |
Crystal Bioscience, Inc. | California | |
Icagen, LLC | Delaware | |
Taurus Biosciences, LLC | Delaware | |
xCella Biosciences, Inc. | Delaware |